Beyond Hemoglobin: New Surrogate Endpoints Finding Use In Diabetes Trials
Executive Summary
CHICAGO -With diabetes studies that evaluate glycemic control receiving criticism, industry has started conducting trials utilizing alternative surrogate endpoints